Inventor · disambiguated record
Ling Chen
Also filed as: CHEN LING · CHEN LING-CHIEH
41 granted patents·24 pending applications·129 citations·filing 2002–2025
96Inventor score
Files withBRISTOL MYERS SQUIBB CO16SHANGHAI FOCHON PHARMACEUTICAL CO LTD9CATHAY BIOTECH INC7GUANGZHOU N BIOMED LTD6UNIV SOUTH CHINA TECH4
Top patents by PatentIndex Score
65 records- 0197US9902722B2Biaryl kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Feb 27, 2018·19 cites·13 claims
- 0295US11021462B2Sulfone pyridine alkyl amide-substituted heteroaryl compoundsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jun 1, 2021·6 cites·28 claims
- 0394US11787779B2Sulfone pyridine alkyl amide-substituted heteroaryl compoundsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Oct 17, 2023·2 cites·4 claims
- 0493US10550080B2Acyl sulfonamide NaV1.7 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Feb 4, 2020·8 cites·9 claims
- 0590US10752609B2GSK-3 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Aug 25, 2020·6 cites·10 claims
- 0688US7314883B2Anti-migraine treatmentsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Jan 1, 2008·12 cites·36 claims
- 0788US6916812B2Alpha-aminoamide derivatives as melanocortin agonistsBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Jul 12, 2005·23 cites·7 claims
- 0887US7842808B2Anti-migraine spirocyclesBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Nov 30, 2010·13 cites·36 claims
- 0986US12365667B2Sulfone pyridine alkyl amide-substituted heteroaryl compoundsBRISTOL MYERS SQUIBB CO·Filed 2023·Granted Jul 22, 2025·0 cites·13 claims
- 1083US2025304555A1Sulfone pyridine alkyl amide-substituted heteroaryl compoundsBRISTOL MYERS SQUIBB CO·Filed 2025·Application pending·0 cites
- 1180US9718804B2GSK-3 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Aug 1, 2017·5 cites·6 claims
- 1280US7569578B2Heterocyclic anti-migraine agentsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Aug 4, 2009·14 cites·31 claims
- 1379US10544120B2Biaryl kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jan 28, 2020·2 cites·3 claims
- 1479US7220862B2Calcitonin gene related peptide receptor antagonistsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted May 22, 2007·11 cites·36 claims
- 1577US12325872B2Method of improving acid decarboxylase activity in vitro under alkaline pHCATHAY BIOTECH INC·Filed 2023·Granted Jun 10, 2025·0 cites·6 claims
- 1677US9714235B2Quinazoline derivatives, compositions thereof, and use as pharmaceuticalsSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2014·Granted Jul 25, 2017·3 cites·2 claims
- 1773US9206166B2Certain protein kinase inhibitorsSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2013·Granted Dec 8, 2015·2 cites·20 claims
- 1871US10246469B2Biaryl kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Apr 2, 2019·1 cites·8 claims
- 1971US9556171B2Certain protein kinase inhibitorsSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2014·Granted Jan 31, 2017·2 cites·15 claims
- 2067US2022056422A1Application of utx gene in preparation of drugs for preventing or treating lipid diseasesNANJING MATERNITY & CHILD HEALTH CARE HOSPITAL·Filed 2021·Application pending·0 cites
- 2165US2020024580A1Application of utx gene in preparation of drugs for preventing or treating lipid diseasesNANJING MATERNITY & CHILD HEALTH CARE HOSPITAL·Filed 2019·Application pending·0 cites
- 2265US2024218389A1METHODS FOR CONSTRUCTING TRANSGENIC PLANTS COMPRISING TaPDIL4-1B GENEINST OF GRAIN CROPS HUBEI ACADEMY OF AGRICULTURAL SCIENCES·Filed 2024·Application pending·0 cites
- 2364US11839219B2BVP10 protein for controlling tetranychid mites and use thereofHUBEI BIOPESTICIDE ENGINEERING RES CENTER·Filed 2022·Granted Dec 12, 2023·0 cites·6 claims
- 2464US11793204B2BVP8 protein for killing Tetranychid mites and use thereofHUBEI BIOPESTICIDE ENGINEERING RES CENTER·Filed 2022·Granted Oct 24, 2023·0 cites·8 claims
- 2561US2024390450A1Polypeptide, polypeptide fragment, derivative thereof, and applications thereofCHENGDU HUITAI BIOMEDICINE CO LTD·Filed 2024·Application pending·0 cites
- 2659US12447212B2Starch-based carrier material with M cell targeting performance and pH responsiveness, and preparation method therefor and use thereofUNIV SOUTH CHINA TECH·Filed 2019·Granted Oct 21, 2025·0 cites·10 claims
- 2758US2025134874A1Pharmaceutical formulations comprising 3-({[(4r)-7-{methyl[4-(propan-2-yl)phenyl]amino}-3,4-dihydro-2h-1-benzopyran-4-yl]methyl}amino)pyridine-4-carboxylic acidTACHYON THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2857US2020138079A13d printing technology-based method for use in adjusting digestibility of highland barley starchUNIV SOUTH CHINA TECH·Filed 2017·Application pending·0 cites
- 2953US2023133364A1Novel coronavirus vaccine based on influenza virus vector and preparation method thereofGUANGZHOU N BIOMED LTD·Filed 2021·Application pending·0 cites
- 3052US2025122191A1Compounds as bcl-2 inhibitorsFOCHON BIOSCIENCES LTD·Filed 2022·Application pending·0 cites
- 3151US12128097B2AD35-vectored immunogenic composition for SARS-COV-2 infectionGUANGZHOU N BIOMED LTD·Filed 2021·Granted Oct 29, 2024·0 cites·19 claims
- 3251US11781163B2Reducing the accumulation of imines/enamines for the production of amino acids or amino acid-derived productsCATHAY BIOTECH INC·Filed 2017·Granted Oct 10, 2023·0 cites·14 claims
- 3351US2023159527A1Compounds as bcl-2 inhibitorsFOCHON PHARMACEUTICALS LTD·Filed 2021·Application pending·0 cites
- 3450US2022347289A1Nucleotide sequences encoding peptide antigens of sars-cov-2 virus and use thereofGUANGZHOU N BIOMED LTD·Filed 2020·Application pending·0 cites
- 3549US2019330613A1Control of protein to protein interactions of acid decarboxylaseCATHAY R&D CENTER CO LTD·Filed 2016·Application pending·0 cites
- 3649US2022354860A1Heterocyclic derivatives and use thereofFOCHON PHARMACEUTICALS LTD·Filed 2020·Application pending·0 cites
- 3748US12011475B2Polypeptide, polypeptide fragment, derivative thereof, and applications thereofCHENGDU HUITAI BIOMEDICINE CO LTD·Filed 2018·Granted Jun 18, 2024·0 cites·6 claims
- 3848US10463716B2Methods for treating cardiovascular dysfunction and improving fluid homeostasis with Elabela peptide hormoneUNIV MARYLAND·Filed 2015·Granted Nov 5, 2019·0 cites·10 claims
- 3948US2022282046A1Cyclodextrin-based metal organic framework material and preparation method thereforUNIV SOUTH CHINA TECH·Filed 2019·Application pending·0 cites
- 4048US2021283244A1Adenovirus-vectored vaccine for preventing sars-cov-2 infectionGUANGZHOU N BIOMED LTD·Filed 2020·Application pending·0 cites
- 4147US10053449B2Quinazoline derivatives, compositions thereof, and use as pharmaceuticalsSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2017·Granted Aug 21, 2018·0 cites·3 claims
- 4247US9424476B2Method for detecting a vehicle sunvisor's stateUNIV SUN YAT SEN·Filed 2013·Granted Aug 23, 2016·0 cites·9 claims
- 4347US2004063735A1Calcitonin gene related peptide receptor antagonistsFiled 2003·Application pending·0 cites
- 4447US2023135215A1Compounds as cdk2/4/6 inhibitorsFOCHON BIOSCIENCES LTD·Filed 2021·Application pending·0 cites
- 4546US10835535B2Certain protein kinase inhibitorsSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2017·Granted Nov 17, 2020·0 cites·17 claims
- 4646US9809573B2Substituted pyridine derivatives useful as GSK-3 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Nov 7, 2017·0 cites·3 claims
- 4746US2018230239A1A starch-based food thickener with low molecular weight and a preparation method thereofUNIV SOUTH CHINA TECH·Filed 2015·Application pending·0 cites
- 4845US10022374B2Certain protein kinase inhibitorsSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2016·Granted Jul 17, 2018·0 cites·13 claims
- 4944US11512302B2Modifications to lysine decarboxylase enzymesCATHAY BIOTECH INC·Filed 2017·Granted Nov 29, 2022·0 cites·17 claims
- 5044US11118201B2Heterologous expression of carbohydrate binding modules and uses thereof for cadaverine productionCATHAY BIOTECH INC·Filed 2017·Granted Sep 14, 2021·0 cites·12 claims
Showing the top 50 of 65 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Ling Chen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →